14.10 USD
↘ 0.05 (0.38%)PRE MARKET (AS OF 05:09 AM EST)
Shares of Crescent Biopharma, Inc. Common Stock (CBIO) are trading at $14.10. Technicals currently rate "Neutral" while our fundamental analysis reads "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. CBIO is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Nov 13, 2026.